AbbVie Inc (LTS:0QCV)
$ 174.92 -0.4 (-0.23%) Market Cap: 302.34 Bil Enterprise Value: 366.13 Bil PE Ratio: 60.57 PB Ratio: 51.09 GF Score: 86/100

Abbvie Inc at Cowen Health Care Conference Transcript

Mar 07, 2023 / 02:10PM GMT
Release Date Price: $154.35 (-0.69%)
Stephen Michael Scala
TD Cowen, Research Division - MD & Senior Research Analyst

Conference again this year. We have 4 members of management. By the way, I don't have a mic, so I'm just going to talk loudly. Hopefully, you can all hear the questions. But we have 4 members of management here with us, Rob Michael, who is Vice Chairman and President; Scott Reents, who is Executive Vice President and Chief Financial Officer; Jeff Stewart, who's Executive Vice President and Chief Commercial Officer; and Roopal Thakkar, who is Senior Vice President of Development and Regulatory Affairs as well as Chief Medical Officer. So a lot's going on at AbbVie these days, so let's jump right in.

Questions & Answers

Stephen Michael Scala;
TD Cowen, Research Division - MD & Senior Research Analyst

In no particular order, let's start out with the kind of the future-looking type of question. What new indications and pipeline programs could generate Phase III go, no-go decisions this year that we as investors can look forward to as milestones?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot